Abstract
Milestone Scientific and Milestone China form new dermatological joint venture. BGI and The Vancouver Prostate Centre to create joint research laboratory for advancement of translational cancer research. Ioxus to be incorporated in China as Ioxus (Shanghai) Clean Energy Technology. Tsinghua and UC Berkeley launch research and graduate education partnership. Altor BioScience and Shenzhen Beike Biotechnology enter license agreement for immunotherapeutic ALT-803 in China. 3SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
